proguanil hydrochloride
CLINICAL USE
Malaria chemoprophylaxis
DOSE IN NORMAL RENAL FUNCTION
200 mg daily
PHARMACOKINETICS
Molecular weight                           :290.2 %Protein binding                           :75 %Excreted unchanged in urine     : 60 Volume of distribution (L/kg)       :No datahalf-life – normal/ESRD (hrs)      :20 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20–60 100 mg daily 10 to 20     : 50 mg every 48 hours <10           : 50 mg weekly DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely to be dialysed. Dose as in GFR <10 mL/min HD                     :Not dialysed. Dose as in GFR <10 mL/minHDF/high flux   :Unknown dialysability. Dose as in GFR <10 mL/minCAV/VVHD      :Unknown dialysability. Dose as in GFR 10 to 20 mL/min IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnticoagulants: effect of warfarin possibly enhancedAntimalarials: avoid concomitant use with artemether/lumefantrine; increased antifolate effect with pyrimethamine ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
– OTHER INFORMATION
Rare reports of haematological changes (e.g. megaloblastic anaemia and pancytopenia) in patients with severe renal impairment
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home